ACELRX PHARMACEUTICALS INC (ACRX) has 68 open-market insider trades by 23 insiders since 2011. The most active filer is Mark G. Edwards, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark A. Wan | Dir | — | 1 | $12.4M | 2023-10-10 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 6 | $10.8M | 2017-06-19 |
| Joseph Edelman | 10% Owner | — | 2 | $10.8M | 2016-09-29 |
| Wilfred E. Jaeger | 10% | — | 2 | $9.0M | 2012-12-07 |
| Stephen J. Hoffman | Dir | — | 2 | $7.1M | 2023-10-10 |
| Arch Associates Iv Lp Three | 10% | — | 1 | $6.4M | 2011-02-16 |
| Arch Management Iii Llc Three | 10% | — | 1 | $6.4M | 2011-02-16 |
| Guy P. Nohra | Dir | — | 1 | $3.4M | 2013-09-20 |
| David Henry Mack | 10% | — | 1 | $3.4M | 2011-02-16 |
| Perceptive Advisors LLC | 10% | — | 2 | $1.7M | 2015-11-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Vincent J. Angotti | CEO | Buy | $7K | 2023-12-13 |
| Vincent J. Angotti | CEO | Buy | $8K | 2023-09-11 |
| Pamela P. Palmer | Chief Medical Officer | Sell | $19K | 2023-08-24 |
| Vincent J. Angotti | CEO | Buy | $10K | 2022-06-07 |
| Adrian Adams | Director | Buy | $129K | 2020-06-15 |
| Vincent J. Angotti | CEO | Buy | $10K | 2020-06-15 |
Companies that share insiders with ACRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark G. Edwards | Director | Buy | $45K | 2019-11-12 |
| Vincent J. Angotti | CEO | Buy | $15K | 2019-11-11 |
| Mark G. Edwards | Director | Buy | $33K | 2019-08-23 |
| Vincent J. Angotti | CEO | Buy | $12K | 2019-06-05 |
| Mark G. Edwards | Director | Buy | $114K | 2019-03-12 |
| Badri N. Dasu | Chief Engineering Officer | Buy | $26K | 2019-02-28 |
| Pamela P. Palmer | Chief Medical Officer | Buy | $2K | 2019-02-28 |
| Lawrence G. Hamel | Chief Development Officer | Buy | $10K | 2019-02-28 |
| Vincent J. Angotti | CEO | Buy | $9K | 2019-02-28 |